| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Prenatal | 15 | 2021 | 1008 | 3.570 |
Why?
|
| HLA Antigens | 7 | 2021 | 220 | 3.170 |
Why?
|
| Pregnancy | 42 | 2024 | 7602 | 1.930 |
Why?
|
| Pregnancy, Twin | 4 | 2018 | 189 | 1.640 |
Why?
|
| Blood Donors | 4 | 2021 | 61 | 1.440 |
Why?
|
| Birth Weight | 6 | 2020 | 356 | 1.380 |
Why?
|
| Pregnancy Outcome | 11 | 2020 | 637 | 1.340 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 2016 | 105 | 1.280 |
Why?
|
| Pregnancy Trimesters | 3 | 2018 | 34 | 1.260 |
Why?
|
| Fetal Weight | 3 | 2020 | 72 | 1.010 |
Why?
|
| Antibodies | 2 | 2020 | 372 | 0.970 |
Why?
|
| Histocompatibility Testing | 6 | 2017 | 111 | 0.940 |
Why?
|
| Body Mass Index | 5 | 2020 | 1713 | 0.890 |
Why?
|
| Kidney Transplantation | 5 | 2020 | 575 | 0.890 |
Why?
|
| Heart Valve Diseases | 2 | 2016 | 181 | 0.870 |
Why?
|
| Infant, Small for Gestational Age | 3 | 2020 | 61 | 0.810 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2023 | 491 | 0.800 |
Why?
|
| Arthrogryposis | 2 | 2019 | 40 | 0.790 |
Why?
|
| Trial of Labor | 3 | 2019 | 23 | 0.780 |
Why?
|
| Vaginal Birth after Cesarean | 3 | 2019 | 23 | 0.780 |
Why?
|
| Social Determinants of Health | 2 | 2023 | 158 | 0.750 |
Why?
|
| Limb Deformities, Congenital | 2 | 2019 | 112 | 0.740 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 964 | 0.720 |
Why?
|
| Fetal Development | 3 | 2018 | 135 | 0.700 |
Why?
|
| Transfusion-Related Acute Lung Injury | 1 | 2020 | 2 | 0.700 |
Why?
|
| Female | 53 | 2024 | 71503 | 0.690 |
Why?
|
| Placenta | 5 | 2021 | 550 | 0.690 |
Why?
|
| Heart Defects, Congenital | 5 | 2019 | 1887 | 0.680 |
Why?
|
| Pregnancy, Multiple | 3 | 2011 | 48 | 0.670 |
Why?
|
| Isoantibodies | 4 | 2021 | 59 | 0.660 |
Why?
|
| Plasma | 1 | 2020 | 105 | 0.660 |
Why?
|
| Adult | 33 | 2024 | 31684 | 0.650 |
Why?
|
| Clubfoot | 1 | 2019 | 21 | 0.650 |
Why?
|
| Alleles | 5 | 2020 | 1697 | 0.650 |
Why?
|
| Polydactyly | 1 | 2019 | 18 | 0.640 |
Why?
|
| Genotype | 4 | 2020 | 2720 | 0.630 |
Why?
|
| Fetal Growth Retardation | 2 | 2020 | 257 | 0.620 |
Why?
|
| Humans | 64 | 2024 | 133373 | 0.610 |
Why?
|
| Fetofetal Transfusion | 2 | 2012 | 194 | 0.610 |
Why?
|
| Extremities | 1 | 2019 | 87 | 0.610 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 202 | 0.600 |
Why?
|
| Cervix Uteri | 2 | 2017 | 63 | 0.600 |
Why?
|
| Chorionic Villi Sampling | 5 | 2019 | 46 | 0.590 |
Why?
|
| Twins, Dizygotic | 1 | 2018 | 47 | 0.590 |
Why?
|
| Adipose Tissue | 2 | 2018 | 509 | 0.590 |
Why?
|
| Pregnancy Trimester, Second | 4 | 2020 | 170 | 0.580 |
Why?
|
| Kidney Function Tests | 1 | 2018 | 132 | 0.570 |
Why?
|
| Monitoring, Physiologic | 3 | 2016 | 384 | 0.560 |
Why?
|
| HLA-DP beta-Chains | 1 | 2017 | 10 | 0.550 |
Why?
|
| Allografts | 1 | 2018 | 199 | 0.550 |
Why?
|
| Episiotomy | 1 | 2017 | 17 | 0.550 |
Why?
|
| Absorbent Pads | 1 | 2017 | 1 | 0.540 |
Why?
|
| Perineum | 1 | 2017 | 48 | 0.540 |
Why?
|
| Unrelated Donors | 1 | 2017 | 70 | 0.540 |
Why?
|
| Professional Staff Committees | 1 | 2016 | 6 | 0.530 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2016 | 12 | 0.530 |
Why?
|
| Obstetric Labor, Premature | 1 | 2017 | 85 | 0.530 |
Why?
|
| Graft Survival | 2 | 2018 | 482 | 0.520 |
Why?
|
| Peer Review | 1 | 2016 | 41 | 0.520 |
Why?
|
| Amniocentesis | 4 | 2019 | 77 | 0.510 |
Why?
|
| Gynecology | 2 | 2021 | 129 | 0.510 |
Why?
|
| Oxytocics | 1 | 2016 | 28 | 0.500 |
Why?
|
| Benchmarking | 1 | 2017 | 146 | 0.500 |
Why?
|
| Statistics as Topic | 1 | 2017 | 256 | 0.500 |
Why?
|
| Fetal Distress | 1 | 2016 | 12 | 0.500 |
Why?
|
| Maternal-Fetal Relations | 1 | 2016 | 16 | 0.500 |
Why?
|
| Labor, Induced | 1 | 2016 | 34 | 0.500 |
Why?
|
| Proteins | 2 | 2018 | 1090 | 0.500 |
Why?
|
| Microarray Analysis | 4 | 2019 | 238 | 0.490 |
Why?
|
| Gestational Age | 6 | 2021 | 1231 | 0.490 |
Why?
|
| Cesarean Section | 3 | 2021 | 402 | 0.490 |
Why?
|
| Oxytocin | 1 | 2016 | 74 | 0.490 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 1205 | 0.490 |
Why?
|
| Energy Intake | 1 | 2018 | 515 | 0.480 |
Why?
|
| Body Composition | 1 | 2018 | 563 | 0.480 |
Why?
|
| Postpartum Hemorrhage | 1 | 2017 | 108 | 0.480 |
Why?
|
| Bradycardia | 1 | 2016 | 62 | 0.480 |
Why?
|
| Biopsy | 2 | 2018 | 1204 | 0.480 |
Why?
|
| Heart Rate, Fetal | 1 | 2016 | 63 | 0.480 |
Why?
|
| Pertussis Vaccine | 1 | 2015 | 25 | 0.470 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 3105 | 0.470 |
Why?
|
| Twins | 4 | 2013 | 73 | 0.470 |
Why?
|
| Obstetrics | 2 | 2021 | 240 | 0.460 |
Why?
|
| Pneumothorax | 1 | 2016 | 82 | 0.460 |
Why?
|
| Pulmonary Edema | 1 | 2015 | 60 | 0.450 |
Why?
|
| Diagnosis, Differential | 5 | 2019 | 1973 | 0.440 |
Why?
|
| Pregnancy Complications | 2 | 2016 | 553 | 0.430 |
Why?
|
| Energy Metabolism | 1 | 2018 | 815 | 0.410 |
Why?
|
| Antibodies, Bacterial | 1 | 2015 | 401 | 0.400 |
Why?
|
| Delivery, Obstetric | 5 | 2024 | 260 | 0.390 |
Why?
|
| Genotyping Techniques | 3 | 2017 | 110 | 0.390 |
Why?
|
| Graft Rejection | 2 | 2018 | 566 | 0.380 |
Why?
|
| Biological Assay | 1 | 2013 | 111 | 0.380 |
Why?
|
| Infant, Newborn | 10 | 2022 | 8632 | 0.380 |
Why?
|
| Heart-Lung Transplantation | 1 | 2011 | 24 | 0.360 |
Why?
|
| Amniotic Band Syndrome | 3 | 2019 | 24 | 0.360 |
Why?
|
| HLA-B Antigens | 1 | 2011 | 30 | 0.360 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2015 | 475 | 0.360 |
Why?
|
| Prenatal Care | 3 | 2020 | 361 | 0.350 |
Why?
|
| Umbilical Cord | 1 | 2011 | 59 | 0.350 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2019 | 399 | 0.350 |
Why?
|
| Critical Care | 1 | 2016 | 698 | 0.350 |
Why?
|
| DNA | 1 | 2016 | 1676 | 0.340 |
Why?
|
| Retrospective Studies | 16 | 2024 | 17568 | 0.330 |
Why?
|
| Ciliary Motility Disorders | 2 | 2019 | 13 | 0.330 |
Why?
|
| Polycystic Kidney Diseases | 2 | 2019 | 33 | 0.320 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2009 | 18 | 0.320 |
Why?
|
| Genetic Testing | 4 | 2019 | 1101 | 0.320 |
Why?
|
| Vaccination | 1 | 2015 | 1019 | 0.320 |
Why?
|
| Encephalocele | 2 | 2019 | 48 | 0.310 |
Why?
|
| Basal Metabolism | 2 | 2020 | 94 | 0.310 |
Why?
|
| Fertilization in Vitro | 2 | 2021 | 163 | 0.310 |
Why?
|
| Aneuploidy | 1 | 2009 | 145 | 0.300 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 1191 | 0.300 |
Why?
|
| Retinitis Pigmentosa | 2 | 2019 | 97 | 0.300 |
Why?
|
| Acute Lung Injury | 3 | 2014 | 68 | 0.290 |
Why?
|
| Placenta Diseases | 1 | 2008 | 61 | 0.290 |
Why?
|
| Referral and Consultation | 1 | 2012 | 574 | 0.290 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2020 | 124 | 0.280 |
Why?
|
| Obstetric Labor Complications | 1 | 2008 | 99 | 0.280 |
Why?
|
| Tissue Donors | 1 | 2011 | 507 | 0.270 |
Why?
|
| Prospective Studies | 5 | 2018 | 6582 | 0.270 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 237 | 0.270 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 3043 | 0.270 |
Why?
|
| Texas | 4 | 2023 | 3666 | 0.260 |
Why?
|
| Prenatal Diagnosis | 3 | 2021 | 633 | 0.240 |
Why?
|
| Thrombocytopenia | 2 | 2019 | 237 | 0.240 |
Why?
|
| Sensitivity and Specificity | 4 | 2021 | 2142 | 0.240 |
Why?
|
| Receptors, Cytokine | 1 | 2005 | 67 | 0.240 |
Why?
|
| Megakaryocytes | 1 | 2005 | 45 | 0.240 |
Why?
|
| Perinatology | 2 | 2022 | 35 | 0.230 |
Why?
|
| Siblings | 1 | 2005 | 202 | 0.220 |
Why?
|
| Enoxaparin | 1 | 2024 | 49 | 0.210 |
Why?
|
| RNA Splicing | 1 | 2005 | 254 | 0.210 |
Why?
|
| Transfusion Reaction | 2 | 2014 | 39 | 0.210 |
Why?
|
| Weight Gain | 2 | 2018 | 412 | 0.210 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2024 | 62 | 0.210 |
Why?
|
| Trisomy 13 Syndrome | 2 | 2019 | 19 | 0.200 |
Why?
|
| Obesity | 2 | 2018 | 2440 | 0.200 |
Why?
|
| Angioedemas, Hereditary | 1 | 2022 | 8 | 0.200 |
Why?
|
| Angioedema | 1 | 2022 | 23 | 0.200 |
Why?
|
| Male | 14 | 2021 | 65592 | 0.190 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 1340 | 0.190 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 624 | 0.180 |
Why?
|
| Algorithms | 1 | 2009 | 1730 | 0.180 |
Why?
|
| Middle Aged | 10 | 2021 | 28985 | 0.180 |
Why?
|
| Venous Thromboembolism | 1 | 2024 | 187 | 0.180 |
Why?
|
| Convalescence | 1 | 2020 | 4 | 0.180 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2020 | 14 | 0.170 |
Why?
|
| Pharmacogenomic Testing | 1 | 2020 | 45 | 0.170 |
Why?
|
| Healthcare Disparities | 2 | 2022 | 484 | 0.160 |
Why?
|
| Pallister-Hall Syndrome | 1 | 2019 | 3 | 0.160 |
Why?
|
| Case-Control Studies | 5 | 2020 | 3418 | 0.160 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2019 | 8 | 0.160 |
Why?
|
| Minority Groups | 1 | 2022 | 251 | 0.160 |
Why?
|
| Carpal Bones | 1 | 2019 | 6 | 0.160 |
Why?
|
| Risk Assessment | 5 | 2016 | 3718 | 0.160 |
Why?
|
| Breech Presentation | 1 | 2019 | 20 | 0.160 |
Why?
|
| Prognosis | 2 | 2019 | 5044 | 0.160 |
Why?
|
| Laboratories | 1 | 2020 | 89 | 0.160 |
Why?
|
| Acrocephalosyndactylia | 1 | 2019 | 22 | 0.160 |
Why?
|
| Thumb | 1 | 2019 | 30 | 0.160 |
Why?
|
| Radius | 1 | 2019 | 36 | 0.160 |
Why?
|
| Blood Group Incompatibility | 2 | 2016 | 27 | 0.160 |
Why?
|
| Pierre Robin Syndrome | 1 | 2019 | 31 | 0.160 |
Why?
|
| Exons | 2 | 2017 | 825 | 0.160 |
Why?
|
| Bone Diseases, Developmental | 1 | 2019 | 61 | 0.160 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2019 | 47 | 0.160 |
Why?
|
| Oligohydramnios | 1 | 2019 | 48 | 0.160 |
Why?
|
| Pharmacogenetics | 1 | 2020 | 200 | 0.160 |
Why?
|
| Anticoagulants | 1 | 2024 | 628 | 0.150 |
Why?
|
| Polyhydramnios | 1 | 2019 | 56 | 0.150 |
Why?
|
| Sex Distribution | 1 | 2019 | 321 | 0.150 |
Why?
|
| Body Fluid Compartments | 1 | 2018 | 19 | 0.150 |
Why?
|
| Young Adult | 9 | 2019 | 9923 | 0.150 |
Why?
|
| Body Water | 1 | 2018 | 89 | 0.150 |
Why?
|
| Ultrasonography, Interventional | 2 | 2013 | 207 | 0.150 |
Why?
|
| Hemoglobins | 1 | 2020 | 322 | 0.150 |
Why?
|
| Hemorrhage | 1 | 2022 | 519 | 0.140 |
Why?
|
| Cerclage, Cervical | 1 | 2018 | 12 | 0.140 |
Why?
|
| Pregnancy Reduction, Multifetal | 2 | 2008 | 20 | 0.140 |
Why?
|
| Placenta Accreta | 1 | 2021 | 169 | 0.140 |
Why?
|
| Myotonic Dystrophy | 1 | 2019 | 151 | 0.140 |
Why?
|
| Apgar Score | 1 | 2018 | 49 | 0.140 |
Why?
|
| Nutritional Requirements | 1 | 2018 | 180 | 0.140 |
Why?
|
| Health Information Interoperability | 1 | 2017 | 5 | 0.140 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 313 | 0.140 |
Why?
|
| Body Height | 1 | 2018 | 228 | 0.140 |
Why?
|
| Inservice Training | 1 | 2017 | 56 | 0.130 |
Why?
|
| Lymphocyte Depletion | 1 | 2017 | 125 | 0.130 |
Why?
|
| Hospitals, University | 1 | 2017 | 107 | 0.130 |
Why?
|
| Reference Values | 1 | 2018 | 724 | 0.130 |
Why?
|
| Rho(D) Immune Globulin | 1 | 2016 | 12 | 0.130 |
Why?
|
| Cell-Free System | 1 | 2016 | 99 | 0.130 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2016 | 16 | 0.130 |
Why?
|
| False Negative Reactions | 1 | 2016 | 83 | 0.130 |
Why?
|
| Virus Diseases | 1 | 2019 | 291 | 0.130 |
Why?
|
| Time Factors | 4 | 2020 | 6544 | 0.130 |
Why?
|
| Postpartum Period | 1 | 2018 | 229 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 1137 | 0.130 |
Why?
|
| Gene Library | 1 | 2017 | 224 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 306 | 0.130 |
Why?
|
| False Positive Reactions | 1 | 2016 | 140 | 0.130 |
Why?
|
| Emigrants and Immigrants | 1 | 2019 | 156 | 0.130 |
Why?
|
| Risk Adjustment | 1 | 2016 | 60 | 0.130 |
Why?
|
| Maternal Mortality | 1 | 2017 | 81 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 2288 | 0.130 |
Why?
|
| Patient Care Management | 1 | 2016 | 68 | 0.130 |
Why?
|
| Sacrum | 1 | 2016 | 31 | 0.120 |
Why?
|
| Quality Improvement | 1 | 2022 | 701 | 0.120 |
Why?
|
| Labor, Obstetric | 1 | 2016 | 97 | 0.120 |
Why?
|
| Mortality | 1 | 2017 | 261 | 0.120 |
Why?
|
| Transplantation Conditioning | 1 | 2017 | 300 | 0.120 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 651 | 0.120 |
Why?
|
| Mothers | 1 | 2018 | 373 | 0.120 |
Why?
|
| Directive Counseling | 1 | 2015 | 24 | 0.120 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 114 | 0.120 |
Why?
|
| Orthopedic Procedures | 1 | 2016 | 76 | 0.110 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2015 | 87 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 385 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 395 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2017 | 823 | 0.110 |
Why?
|
| Hematologic Neoplasms | 1 | 2017 | 294 | 0.110 |
Why?
|
| Hypotension | 1 | 2016 | 188 | 0.110 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2013 | 21 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 767 | 0.110 |
Why?
|
| Robotic Surgical Procedures | 1 | 2018 | 234 | 0.110 |
Why?
|
| Living Donors | 1 | 2014 | 116 | 0.110 |
Why?
|
| Complement C3 | 1 | 2013 | 54 | 0.110 |
Why?
|
| Guideline Adherence | 1 | 2016 | 395 | 0.110 |
Why?
|
| Telemedicine | 1 | 2020 | 507 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 1583 | 0.100 |
Why?
|
| Histocompatibility | 1 | 2013 | 42 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 659 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 84 | 0.100 |
Why?
|
| Laparoscopy | 1 | 2018 | 520 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1193 | 0.100 |
Why?
|
| Preconception Care | 1 | 2012 | 16 | 0.100 |
Why?
|
| Software | 1 | 2017 | 732 | 0.100 |
Why?
|
| Exercise | 1 | 2018 | 873 | 0.100 |
Why?
|
| Graft vs Host Disease | 1 | 2017 | 619 | 0.090 |
Why?
|
| Genome, Human | 1 | 2019 | 1340 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2019 | 1140 | 0.090 |
Why?
|
| Postnatal Care | 1 | 2012 | 52 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 7141 | 0.090 |
Why?
|
| Decision Making | 1 | 2017 | 702 | 0.090 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2012 | 37 | 0.090 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2012 | 88 | 0.090 |
Why?
|
| Abortion, Induced | 1 | 2012 | 81 | 0.090 |
Why?
|
| Mutation | 1 | 2005 | 6343 | 0.090 |
Why?
|
| Risk Factors | 4 | 2020 | 10954 | 0.090 |
Why?
|
| Aged | 6 | 2021 | 21500 | 0.090 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2012 | 184 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2015 | 578 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 1830 | 0.090 |
Why?
|
| Phenotype | 1 | 2020 | 4577 | 0.080 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2012 | 359 | 0.080 |
Why?
|
| Adolescent | 6 | 2022 | 20573 | 0.080 |
Why?
|
| Electrocardiography | 1 | 2015 | 997 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2019 | 5199 | 0.080 |
Why?
|
| Sampling Studies | 1 | 2008 | 78 | 0.070 |
Why?
|
| Nose | 1 | 2009 | 105 | 0.070 |
Why?
|
| Fetal Monitoring | 1 | 2008 | 58 | 0.070 |
Why?
|
| Blood Platelets | 1 | 2011 | 336 | 0.070 |
Why?
|
| Maternal Age | 1 | 2008 | 141 | 0.070 |
Why?
|
| Fetal Diseases | 1 | 2012 | 461 | 0.070 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2008 | 76 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3869 | 0.070 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2007 | 5 | 0.070 |
Why?
|
| Potassium Chloride | 1 | 2007 | 55 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 474 | 0.070 |
Why?
|
| Pregnancy, Ectopic | 1 | 2007 | 23 | 0.070 |
Why?
|
| Survival Rate | 1 | 2012 | 2207 | 0.070 |
Why?
|
| Overweight | 1 | 2009 | 386 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 5443 | 0.060 |
Why?
|
| Heart Transplantation | 1 | 2013 | 887 | 0.060 |
Why?
|
| Thrombopoietin | 1 | 2005 | 33 | 0.060 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2005 | 31 | 0.060 |
Why?
|
| Blood Cell Count | 1 | 2005 | 67 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 896 | 0.060 |
Why?
|
| Prevalence | 1 | 2012 | 2632 | 0.060 |
Why?
|
| Anemia, Aplastic | 1 | 2005 | 62 | 0.060 |
Why?
|
| Methotrexate | 1 | 2007 | 355 | 0.060 |
Why?
|
| Introns | 1 | 2005 | 317 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3171 | 0.050 |
Why?
|
| Blood Transfusion | 2 | 2020 | 296 | 0.050 |
Why?
|
| United States | 4 | 2022 | 11722 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 841 | 0.050 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 2022 | 8 | 0.050 |
Why?
|
| Academic Medical Centers | 2 | 2016 | 336 | 0.050 |
Why?
|
| Child | 5 | 2022 | 25868 | 0.050 |
Why?
|
| Pedigree | 1 | 2005 | 1730 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2005 | 966 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2022 | 129 | 0.040 |
Why?
|
| Receptors, Phospholipase A2 | 1 | 2020 | 4 | 0.040 |
Why?
|
| Gene Expression | 1 | 2005 | 1608 | 0.040 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2020 | 10 | 0.040 |
Why?
|
| Cell Line | 1 | 2005 | 2853 | 0.040 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2019 | 3 | 0.040 |
Why?
|
| Hematologic Tests | 1 | 2020 | 37 | 0.040 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2019 | 7 | 0.040 |
Why?
|
| Aspirin | 1 | 2021 | 231 | 0.040 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2019 | 16 | 0.040 |
Why?
|
| Kidney | 2 | 2019 | 1395 | 0.040 |
Why?
|
| Cicatrix | 1 | 2021 | 124 | 0.040 |
Why?
|
| Fanconi Anemia | 1 | 2019 | 40 | 0.040 |
Why?
|
| Gambia | 1 | 2019 | 29 | 0.040 |
Why?
|
| Anal Canal | 1 | 2019 | 82 | 0.040 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2019 | 20 | 0.040 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2019 | 98 | 0.040 |
Why?
|
| Donor Selection | 1 | 2020 | 58 | 0.040 |
Why?
|
| Central America | 1 | 2019 | 20 | 0.040 |
Why?
|
| South America | 1 | 2019 | 42 | 0.040 |
Why?
|
| Women's Health Services | 1 | 2019 | 14 | 0.040 |
Why?
|
| Spine | 1 | 2019 | 147 | 0.040 |
Why?
|
| Valproic Acid | 1 | 2019 | 168 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 790 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2019 | 117 | 0.040 |
Why?
|
| Mexico | 1 | 2019 | 185 | 0.040 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2019 | 127 | 0.040 |
Why?
|
| Politics | 1 | 2019 | 61 | 0.040 |
Why?
|
| Esophagus | 1 | 2019 | 218 | 0.040 |
Why?
|
| Trachea | 1 | 2019 | 212 | 0.040 |
Why?
|
| Disease | 1 | 2019 | 132 | 0.040 |
Why?
|
| Seasons | 1 | 2019 | 328 | 0.030 |
Why?
|
| Iron | 1 | 2020 | 304 | 0.030 |
Why?
|
| Robotics | 1 | 2018 | 110 | 0.030 |
Why?
|
| Uterus | 1 | 2021 | 587 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2021 | 779 | 0.030 |
Why?
|
| Myosarcoma | 1 | 2016 | 2 | 0.030 |
Why?
|
| Ilium | 1 | 2016 | 22 | 0.030 |
Why?
|
| Live Birth | 1 | 2016 | 72 | 0.030 |
Why?
|
| Time | 1 | 2016 | 101 | 0.030 |
Why?
|
| Fetoscopy | 1 | 2019 | 449 | 0.030 |
Why?
|
| Spinal Neoplasms | 1 | 2016 | 76 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2016 | 338 | 0.030 |
Why?
|
| ABO Blood-Group System | 1 | 2014 | 65 | 0.030 |
Why?
|
| Myocardium | 1 | 2019 | 924 | 0.030 |
Why?
|
| Paraproteinemias | 1 | 2013 | 22 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2019 | 983 | 0.030 |
Why?
|
| Infant | 2 | 2022 | 13243 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2022 | 14873 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2014 | 241 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 1597 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 593 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 2855 | 0.020 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2013 | 154 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 1463 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2013 | 485 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 616 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 3988 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2011 | 416 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 679 | 0.020 |
Why?
|
| Abortion, Therapeutic | 1 | 2007 | 4 | 0.020 |
Why?
|
| Amnion | 1 | 2007 | 40 | 0.020 |
Why?
|
| Uterine Hemorrhage | 1 | 2007 | 43 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2013 | 13103 | 0.020 |
Why?
|
| Injections | 1 | 2007 | 156 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3223 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 3395 | 0.010 |
Why?
|
| Biomarkers | 1 | 2013 | 3415 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 1864 | 0.010 |
Why?
|